# Moderna's experimental influenza vaccine, Mflusiva, will be reviewed by experts.

*biotech · news · 2026-05-21 · MarketScreener*

## Key points

- The FDA will hold a public advisory committee meeting on Moderna's Mflusiva flu vaccine June 18.
- FDA initially rejected Moderna's Mflusiva application in February despite internal disagreements.
- Moderna's flu vaccine would be the first to use mRNA technology for influenza prevention.
- Health Secretary Robert F. Kennedy Jr. has publicly criticized mRNA-based vaccines like Moderna's.

**Companies:** Moderna
**Countries:** United States

[Read the full story on MarketScreener](https://www.marketscreener.com/news/fda-to-hold-review-meeting-for-moderna-s-flu-vaccine-ce7f5aded18cf624)

---

Canonical: https://newsio.io/n/4dde6656-91be-4542-909e-6da3c7449a7e/modernas-experimental-influenza-vaccine-mflusiva-will-be-reviewed-by-experts-the
Summarized by Newsio from MarketScreener. https://newsio.io/how-it-works